Obermatt
See Similar Stocks →

Vor Biopharma

NSQ:VOR · US9290332074
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings30
Price/Book74
Dividend Yield—
Revenue Growth—
Profit Growth51
Capital Growth59
TSR 52w86
Leverage88
Liquidity56
Refinancing55
Combined—
Analyst Opinions36
Pro Holdings47
Opinion Changes50
Market Pulse19

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2015
Employees102
Websitevorbio.com
ISINUS9290332074
Last UpdateApr 2, 2026
Index & Theme
Chronic DiseasesImmunologyGeneticsHematologyRheumatologyStem Cell TherapyOncologyBiotechnologyHealth CarePharmaceutical

Description

Vor Biopharma Inc. (Vor Bio) is a clinical-stage company harnessing the power of cell and genome engineering to develop potentially transformative therapies in acute myeloid leukemia (‘AML’), a devastating disease with few treatment options. Vor Bio…

Similar Stocks

The companies this stock is ranked against.

Compare Vor Biopharma with its peers
Dianthus Therapeutics
NAQ:DNTH
20
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Cabaletta Bio
NSQ:CABA
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Cartesian Therapeutics
NMQ:RNAC
20
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Achieve Life Sciences
NAQ:ACHV
63
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Kyverna Therapeutics
NSQ:KYTX
6
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Stoke Therapeutics
NSQ:STOK
16
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →